Chapter 18. Systemic Lupus Erythematosus

  1. Errol R. Norwitz MD, PhD Professor Director1,
  2. Michael A. Belfort MD, PhD Professor Director2,3,
  3. George R. Saade MD Professor4 and
  4. Hugh Miller MD5

Published Online: 6 MAY 2010

DOI: 10.1002/9781444314489.ch18

Obstetric Clinical Algorithms: Management and Evidence

Obstetric Clinical Algorithms: Management and Evidence

How to Cite

Norwitz, E. R., Belfort, M. A., Saade, G. R. and Miller, H. (2010) Systemic Lupus Erythematosus, in Obstetric Clinical Algorithms: Management and Evidence, Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444314489.ch18

Author Information

  1. 1

    Department of Obstetrics, Gynecology & Reproductive Sciences, Yale-New Haven Hospital, New Haven, CT, USA

  2. 2

    Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, USA

  3. 3

    Perinatal Research and Fetal Therapy Program, HCA Healthcare, Nashville, TN, USA

  4. 4

    Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, USA

  5. 5

    Department of Obstetrics and Gynecology, University of Arizona, Tucson, AZ, USA

Publication History

  1. Published Online: 6 MAY 2010
  2. Published Print: 23 APR 2010

ISBN Information

Print ISBN: 9781405181112

Online ISBN: 9781444314489

SEARCH

Keywords:

  • systemic lupus erythematosus (SLE) - chronic inflammatory disease of unknown cause;
  • immunologic abnormalities - production of antinuclear antibodies;
  • patients with SLE - myriad symptoms and signs;
  • cellular immunity - immunosuppressed in pregnancy;
  • differential diagnosis of SLE - depending on dominant clinical manifestations;
  • frequency of exacerbations - depending on state of disease activity;
  • women with SLE - pregnancy complications;
  • safety in pregnancy - corticosteroids, antimalarials, antihypertensives;
  • high maternal and fetal risk - pulmonary hypertension, restrictive lung disease